What is the main business of Kardiolytics Polska?

The main business activity of Kardiolytics Polska focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 9, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Władysława Pytlasińskiego 10/12, 00-777 Warszawa.

What is the share capital?

The share capital of the company is PLN 272,538 (approx. $73,619).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What was the revenue?

The company reported a revenue of $151,429 in 2020, which is a decrease of 74.3% compared to 2019.

Yes, in 2020 the company achieved a net profit of $71,563.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $35,787 in 2020, representing 62% of all operating expenses.

Kardiolytics PolskaS.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-04-09

Share capital

272,538.00 PLN

Registered address

ul. Władysława Pytlasińskiego 10/12/14, 00-777 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 433 days for 2019). 1 of 3 audited by a statutory auditor.

2021not filed
202022/12/2021
201922/12/2021
201820/08/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2020.

Industry · Other research and experimental development on natural sciences and engineering609 / 1,564

Top 39%

Division · Scientific research and development750 / 1,952

Top 38%

Sector · Professional, scientific and technical activities15,133 / 39,196

Top 39%

Voivodeship · Mazowieckie72,168 / 142,048

Top 51%

Country · Poland260,597 / 495,935

Top 53%

Results vs industry

Revenue

This companyUSD 151.43kMedianUSD 73.59kAverageUSD 3.23m

Net profit

This companyUSD 71.56kMedianUSD 69.14AverageUSD 82.20k

Operating costs

This companyUSD 57.74kMedianUSD 76.19kAverageUSD 3.05m

Assets

This companyUSD 280.21kMedianUSD 120.44kAverageUSD 3.90m

Industry

Authorized Representatives

Krzysztof Borys Siemionowage 49 – President of the Management Board

Cristian Javier Luciano – Management Board Member

Manner of representation

Each member of the management board acting independently is entitled to make declarations of will on behalf of the company and to represent the company.

Supervisory board

Paweł Bohdan Lewicki – Supervisory Board Member

Michał Franciszek Mierzwa – Supervisory Board Member

Łukasz Jan Ochman – Supervisory Board Member

Ownership

Owner	Share value	Stake
Roboticine Inc.	$73,619.12	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2016-04-20 to 2021-11-09.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

1 closed proceeding recorded in KRZ history.

Registration date	Proceeding type	Status
Dec 1, 2025	Discontinued enforcement proceedings	Closed

MSiG notices

Publication date	Event
Sep 15, 2020	Commercial Companies Code notice
Jun 27, 2016	Commercial Companies Code notice

Public aid

Grant date	Purpose	Gross amount	Granting body
Aug 2, 2019	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$4,622$4,622	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Jun 14, 2017	Aid for research and development projects: experimental development	$1.5M$1,526,448	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

Name	Revenue	Website
Centrum Wsparcia Innowacjisp. z o.o.	$219,683.86	cwin.pl
Pharmaxi Polandsp. z o.o.	$152,292.34	pharmaxi.com.ua
Omega Innovationssp. z o.o.	$110,004.52	omegainnovations.eu
Cezamat Pwsp. z o.o.	$119,656.05	cezamat.eu
Recometalsp. z o.o.	$114,425.74	recometal.pl
Bacteromicsp. z o.o.	$112,732.71	bacteromic.com
CPJS - Centrum Promocji Jakości Stalisp. z o.o.	$90,239.54	epstal.pl
Sollersp. z o.o.	$97,199.81	soller-mts.com
New Valuesp. z o.o.	$64,335.86	new-value.pl
CBSsp. z o.o.	$55,382.59	carbonblack.solutions

Change history

Date	Event
2020-10-29	Name change (Holo Surgical → Kardiolytics Polska)
2018-12-07	Share capital increase (247,165.00 PLN → 272,538.00 PLN)
2018-06-19	Share capital increase (233,245.00 PLN → 247,165.00 PLN)
2017-09-19	Share capital increase (219,325.00 PLN → 233,245.00 PLN)
2016-10-25	Share capital increase (172,179.00 PLN → 219,325.00 PLN)

FAQ

Last updated: 2026-04-17